Vicore Pharma Holding AB
- VCRE
- NASDAQ
- Biotechnology
- Interstitial Lung Disease Drugs
- Clinical-Stage Biotech
$8.98
Today −1.21%Quote Oct 16, 2026, 08:00 PM UTC
−13.65%over the last month
Max drawdown −16.7%From 1-month high −13.7%3 months −21.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$253.7M
Quote Oct 16
Next earnings
—
Data unavailable
Analyst target
$25.00
+178.4% from here
Floor
$8.89
1.0% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about VCREPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
37
Founded
2000